Dow Breaks 50 Day Moving Average for First Time in 2013

Andrew Klips |

Ever since dipping below the 50 day simple moving average in the waning days of 2012 and then breaking back above it on the first trading day of 2013, the Dow Jones Industrial Average has held above the key technical component. Note in the image the blue arrows marking periods of consolidation for the Dow chart during the upward trek this year.

INDU June 21 2013

Anytime approaching the 50 dma, the Dow's value turned to climb higher, although the distance between the low of the consolidation and the 50 dma was tightening on each pullback. Earlier this month, the Dow made an intraday dip below the 50 dma only to promptly spark a buying spree to pull back above the moving average. While some technicians interpreted the bounce as a sign of strength in the uptrend, others read it as a cause for concern.

Well, if that move didn't rings some bells of bearishness, on Thursday the Dow plunged through the 50 dma, making a new "lower-low" in the chart and causing the 50 dma to start to flatten. It is also notable that the Dow fell below a support level at 14,900.

Equities are coming out upward on Friday to rally some after a 560-point, two-day, plummet spurred by concerns of weakness in the global economy and possible ending of QE3. The question now is: Will the Dow be able to push back through the fallen support (now resistance) at 14,900? Perhaps even more importantly, will people employing the "buy the dip" mentality be strong enough to get the Dow back over the 50 dma around 15,000? Bulls will likely be cautious until those things happen.

Also note the "lower-high" at 15,340 in June, following the Dow's record high at 15,542 in May. A short-term downtrend is being established since that May peak that is hard to ignore at this point. Every chart has to pull-back at some point; they simply can't go straight-up forever, but this break below a key moving average and the channel forming in the past five weeks has the Dow looking the weakest it has so far this year.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…